Company Overview
Company Type: Public Company
Website: www.alcon.com
Number of Employees: 25,000
Ticker: ALC (SWX)
Year Founded: 1945


Business Description
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company’s Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx laser system, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Financial Information (Currency: CAD, in mm) 
Total Revenue
12,426.3
Market Capitalization
50,610.7
TEV/Total Revenue
4.6x
EBITDA
2,706.8
Total Enterprise Value
56,864.3
TEV/EBITDA
20.1x
EBIT
1,176.3
Cash & ST Invst.
905.5
P/Diluted EPS Before Extra
102.6x
Net Income
495.1
Total Debt
6,985.3
Price/Tang BV
23.1x
Capital Expenditure
(848.0)
Total Assets
39,951.5
Total Debt/EBITDA
2.5x
Currency in CAD in mm, LTM as of Jun-30-2023 TEV and Market Cap are calculated using a close price as of Oct-05-2023


Estimates & Guidance Snapshot (Current Fiscal Year End: Dec-31-2023 | Currency: CAD)
Periodic Estimates
Current FQ
Guidance Current FQ
Current FY
Guidance Current FY
NTM
EPS Normalized
0.91
-
3.75
3.69 - 3.83
4.01
Revenue (mm)
3,216.99
-
13,006.54
12,720.35 - 12,993.91
13,312.45
EBITDA (mm)
784.15
-
3,112.94
-
3,329.02

Forward Multiples (Current FY)

Price/Earnings
27.34x
TEV/REV
4.35x
TEV/EBITDA
18.17x
PEG
1.73x
P/BV
1.87x

Non-Periodic Estimates

Recommendation
Outperform (1.71)
Target Price
131.35
Potential Upside
26.84%
LT Growth (%)
15.82%


Key Professionals
Name
Title
Ball, F. Michael
Executive Chairman
Endicott, David J.
CEO & Director
Stonesifer, Timothy C.
Chief Financial Officer
Buckley, Margaret 
Chief Accounting Officer
Leveiller, Franck 
Senior VP, Head of Global R&D and Chief Scientific Officer
Lin, Sue-Jean 
Senior VP & Chief Information and Transformation Officer
Bedward, Royce R.
Senior VP, General Counsel & Corporate Secretary
Attias, Laurent 
Head of Corporate Development, Strategy, BD&L and M&A
Martin, Kimberly 
Senior VP & Chief HR Officer
Attra, Heather 
Senior VP & Global Head Quality and Regulatory Affairs
Bankes, Jeannette 
President & GM of Global Surgical Franchise
Bell, Ian 
President of Global Business & Innovation

Key Board Members
Name
Title
Ball, F. Michael
Executive Chairman
Endicott, David J.
CEO & Director
Cummings, Arthur B.
Executive Director
Grossman, D. Keith
Independent Director
Maw, Scott Harlan
Independent Director
May, Karen J.
Independent Director
Bleil, Lynn Dorsey
Independent Director
Bono, RaQuel Cruz
Independent Director
Glanzmann, Thomas H.
Independent Director
Poschel, Ines 
Independent Director
Spälti, Dieter
Independent Director


Primary Industry Classification
Health Care Supplies


Primary Office Location
Chemin de Blandonnet 8 Vernier | Geneva, Geneva | 1214 | Switzerland
Phone: 1 817 293 0450   Fax: 1 817 916 2652

Current and Pending Investors
Elo Mutual Pension Insurance Company, Ilmarinen Mutual Pension Insurance Company, Keskinäinen työeläkevakuutusyhtiö Varma, T. Rowe Price Associates, Inc.

Investment Arms
Alcon Inc., Asset Management Arm

Stock Quote and Chart (Currency: CAD)
Last  (Delayed)
 103.55
Market Cap (mm)
51,060.7
Open
 103.28
Shares Out. (mm)
493.1
Previous Close
 103.55
Float %
99.9%
Change on Day
0.36
Shares Sold Short (mm)
-
Change % on Day
0.3%
Dividend Yield %
0.3%
Day High/Low
 104.51/ 102.47
Diluted EPS Excl. Extra Items
1.01
52 wk High/Low
 113.39/ 83.55
P/Diluted EPS Before Extra
102.85x
Volume (mm)
0.67
Avg 3M Dly Vlm (mm)
0.63
Beta 5Y
0.68


 
Delayed Quote** | Last Updated on Oct-06-2023 12:00 AM (GMT-5)
SWX:ALC - Common Stock


Index Membership
S&P Global 1200;S&P Global 1200 Health Care Index;S&P Developed Ex-Asia-Pacific LargeMidCap Value Index;S&P Developed Ex-Australia BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed BMI Value Index;S&P Developed Ex-Asia-Pacific BMI Growth Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific BMI Value Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed BMI Index;S&P Developed Ex-Asia-Pacific BMI Growth Index;S&P Developed Ex-Asia-Pacific BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Growth Index;S&P Developed Ex-Australia BMI Index;S&P Developed Ex-Australia LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Growth Index;S&P Developed BMI Growth Index;S&P Developed Ex-Asia-Pacific BMI Index;S&P Developed Ex-Asia-Pacific BMI Value Index;S&P Developed Ex-Australia LargeMidCap Index;S&P Developed Ex-Australia LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Canada BMI Index;S&P Developed Ex-Canada BMI Health Care (Sector) Index;S&P Developed Ex-Canada LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-U.K. LargeMidCap Health Care (Sector) Index;S&P Developed Ex-U.K. LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Eurozone BMI Index;S&P Developed Ex-Eurozone LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Eurozone LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Japan BMI Index;S&P Developed Ex-Japan BMI Growth Health Care (Sector) Index;S&P Developed Ex-Japan BMI Health Care (Sector) Index;S&P Developed Ex-Japan BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Index;S&P Developed Ex-Australia LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Australia LargeMidCap Value Index;S&P Developed Ex-Japan LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Eurozone LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Australia BMI Growth Index;S&P Developed Ex-Australia BMI Growth Health Care (Sector) Index;S&P Developed Ex-Australia BMI Health Care (Sector) Index;S&P Developed Ex-Australia LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Canada BMI Growth Health Care (Sector) Index;S&P Developed Ex-U.S. & Japan BMI Growth Index;S&P Developed Ex-U.K. BMI Growth Health Care (Sector) Index;S&P Developed Ex-U.K. BMI Health Care (Sector) Index;S&P Developed Ex-U.S. & Japan BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-U.S. & Japan LargeMidCap Index;S&P Developed Ex-U.S. & Japan LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Eurozone BMI Value Health Care (Sector) Index;S&P Developed Ex-U.S. LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-U.S. & U.K. BMI Index;S&P Developed Ex-U.S. & U.K. BMI Growth Index;S&P Developed Ex-U.S. & U.K. LargeMidCap Index;S&P Developed Ex-U.S. & U.K. LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-U.S. BMI Growth Health Care (Sector) Index;S&P Developed Ex-U.S. LargeMidCap Growth Index;S&P EPAC Ex-Japan LargeMidCap Value Index;S&P EPAC LargeMidCap Growth Health Care (Sector) Index;S&P Europe BMI Growth Index;S&P Europe BMI Growth Health Care (Sector) Index;S&P Europe BMI Value Health Care (Sector) Index;S&P Europe Ex-U.K. BMI Growth Index;S&P EPAC Ex-Japan BMI Index;S&P Europe LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Eurozone LargeMidCap Value Index;S&P Developed Ex-Eurozone Over USD5 Billion Index;S&P Developed Ex-Canada BMI Growth Index;S&P Developed Ex-Canada BMI Value Health Care (Sector) Index;S&P Developed Ex-U.K. BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-U.K. BMI Value Health Care (Sector) Index;S&P Developed Ex-U.K. LargeMidCap Index;S&P Developed Ex-U.K. Over USD5 Billion Index;S&P Developed Ex-U.S. & Japan BMI Index;S&P Developed Ex-U.S. & Japan BMI Growth Health Care (Sector) Index;S&P Developed Ex-U.S. & Japan BMI Health Care (Sector) Index;S&P Developed Ex-U.S. & Japan LargeMidCap Growth Index;S&P Europe Ex-U.K. BMI Value Index;S&P Europe Ex-U.K. LargeMidCap Health Care (Sector) Index;S&P Europe Ex-U.K. LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Europe LargeMidCap Index;S&P Developed Ex-U.K. BMI Growth Index;S&P Developed Ex-U.K. BMI Value Index;S&P Developed Ex-U.K. LargeMidCap Growth Index;S&P Developed Ex-U.K. LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-U.K. LargeMidCap Value Index;S&P Developed BMI Health Care (Sector) Index;S&P Developed BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific Over USD5 Billion Index;S&P Developed Ex-Australia BMI Value Health Care (Sector) Index;S&P Developed Ex-Eurozone BMI Growth Health Care (Sector) Index;S&P Developed Ex-Japan BMI Value Health Care (Sector) Index;S&P Developed Ex-Japan LargeMidCap Index;S&P Europe, Mid-East & Africa BMI Index;S&P Europe, Mid-East & Africa BMI Health Care (Sector) Index;S&P Europe, Mid-East & Africa BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-U.S. & Japan BMI Value Index;S&P Developed Ex-U.S. & U.K. LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-U.S. & U.K. LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-U.S. BMI Growth Index;S&P Developed Ex-U.S. BMI Value Health Care (Sector) Index;S&P Developed Ex-U.S. LargeMidCap Health Care (Sector) Index;S&P Developed Ex-U.S. & U.K. BMI Growth Health Care (Sector) Index;S&P Developed Ex-U.S. BMI Index;S&P Developed Ex-U.S. BMI Health Care (Sector) Index;S&P Developed Ex-U.S. BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Australia Over USD5 Billion Index;S&P Developed Ex-Canada LargeMidCap Index;S&P Developed Ex-Canada LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Canada Over USD5 Billion Index;S&P Developed Over USD5 Billion Index;S&P Global Ex-Pan Asia BMI Health Care (Sector) Index;S&P Global Ex-Pan Asia BMI Value Index;S&P EPAC BMI Growth Health Care (Sector) Index;S&P EPAC Ex-Japan BMI Growth Index;S&P EPAC Ex-Japan BMI Value Index;S&P EPAC Ex-Japan BMI Value Health Care (Sector) Index;S&P EPAC Ex-Japan Over USD5 Billion Index;S&P EPAC LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Eurozone BMI Value Index;S&P Developed Ex-Eurozone LargeMidCap Index;S&P Developed Ex-Japan LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Japan LargeMidCap Value Index;S&P Global Ex-U.S. BMI Health Care (Sector) Index;S&P Developed Ex-U.S. LargeMidCap Value Health Care (Sector) Index;S&P Developed LargeMidCap Index;S&P Developed LargeMidCap Growth Index;S&P EPAC BMI Health Care Equipment & Services (Industry Group) Index;S&P EPAC BMI Value Index;S&P EPAC Ex-Japan LargeMidCap Growth Health Care (Sector) Index;S&P EPAC Ex-Japan LargeMidCap Health Care (Sector) Index;S&P EPAC LargeMidCap Index;S&P EPAC Over USD5 Billion Index;S&P Developed Ex-U.S. & U.K. LargeMidCap Health Care (Sector) Index;S&P Europe Ex-U.K. BMI Health Care Equipment & Services (Industry Group) Index;S&P Europe Ex-U.K. LargeMidCap Value Index;S&P Europe, Mid-East & Africa BMI Growth Index;S&P Developed BMI Growth Health Care (Sector) Index;S&P Developed Ex-Australia BMI Value Index;S&P Europe Ex-U.K. BMI Growth Health Care (Sector) Index;S&P Europe Ex-U.K. LargeMidCap Growth Health Care (Sector) Index;S&P Europe Over USD5 Billion Index;S&P Europe, Mid-East & Africa Over USD5 Billion Index;S&P Developed Ex-U.S. & Japan BMI Value Health Care (Sector) Index;S&P Europe, Mid-East & Africa LargeMidCap Health Care (Sector) Index;S&P Developed Ex-U.S. & Japan LargeMidCap Health Care (Sector) Index;S&P Developed Ex-U.S. & Japan LargeMidCap Value Index;S&P Developed Ex-U.S. & U.K. BMI Health Care (Sector) Index;S&P Developed Ex-U.S. & U.K. LargeMidCap Growth Index;S&P Developed Ex-U.S. & U.K. Over USD5 Billion Index;S&P Developed Ex-Canada BMI Value Index;S&P Developed Ex-Canada LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Eurozone BMI Health Care (Sector) Index;S&P Developed Ex-Eurozone LargeMidCap Growth Index;S&P Developed Ex-Japan LargeMidCap Growth Index;S&P Developed Ex-Japan LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Japan Over USD5 Billion Index;S&P Global Ex-Japan LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Global Ex-Japan Over USD5 Billion Index;S&P Global Ex-Pan Asia BMI Health Care Equipment & Services (Industry Group) Index;S&P Global Ex-Pan Asia LargeMidCap Growth Index;S&P Global Ex-U.S. BMI Growth Index;S&P Europe, Mid-East & Africa LargeMidCap Value Index;S&P Developed Ex-U.K. BMI Index;S&P Global Ex-Japan BMI Value Index;S&P Global BMI Index;S&P Global BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Global Ex-U.S. LargeMidCap Growth Index;S&P Global Ex-Japan BMI Health Care (Sector) Index;S&P Global Ex-Japan BMI Health Care Equipment & Services (Industry Group) Index;S&P Global Ex-Japan LargeMidCap Index;S&P Global Ex-Japan LargeMidCap Value Index;S&P Global Ex-Pan Asia LargeMidCap Value Index;S&P Global Ex-Pan Asia Over USD5 Billion Index;S&P Global Ex-U.S. BMI Health Care Equipment & Services (Industry Group) Index;S&P Global Ex-U.S. BMI Value Index;S&P Developed Ex-U.S. BMI Value Index;S&P Developed Ex-U.S. LargeMidCap Growth Health Care (Sector) Index;S&P EPAC BMI Index;S&P EPAC BMI Growth Index;S&P EPAC Ex-Japan BMI Health Care (Sector) Index;S&P EPAC Ex-Japan BMI Health Care Equipment & Services (Industry Group) Index;S&P Europe BMI Index;S&P Europe BMI Value Index;S&P EPAC BMI Health Care (Sector) Index;S&P Europe Ex-U.K. BMI Index;S&P Europe Ex-U.K. BMI Health Care (Sector) Index;S&P Europe Ex-U.K. Over USD5 Billion Index;S&P Europe LargeMidCap Value Index;S&P Europe, Mid-East & Africa LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P EPAC BMI Value Health Care (Sector) Index;S&P EPAC Ex-Japan LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P EPAC LargeMidCap Growth Index;S&P Europe BMI Health Care Equipment & Services (Industry Group) Index;S&P Europe Ex-U.K. LargeMidCap Growth Index;S&P Europe Ex-U.K. LargeMidCap Value Health Care (Sector) Index;S&P Europe LargeMidCap Growth Index;S&P Europe LargeMidCap Value Health Care (Sector) Index;S&P Europe, Mid-East & Africa BMI Value Index;S&P Europe, Mid-East & Africa LargeMidCap Growth Index;S&P Global Ex-Pan Asia LargeMidCap Health Care (Sector) Index;S&P Global Ex-Pan Asia LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Global Ex-U.S. LargeMidCap Value Index;S&P Global LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Global Over USD5 Billion Index;S&P Pan Europe BMI Health Care Equipment & Services (Industry Group) Index;S&P Pan Europe LargeMidCap Index;S&P Pan Europe LargeMidCap Health Care (Sector) Index;S&P Global Ex-Japan LargeMidCap Health Care (Sector) Index;S&P Global Ex-U.S. BMI Index;S&P Switzerland BMI Index;S&P Switzerland LargeMidCap Health Care (Sector) Index;S&P Global LargeMidCap Health Care (Sector) Index;S&P Developed Ex-U.S. & Japan LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-U.S. & Japan Over USD5 Billion Index;S&P Developed Ex-U.S. & U.K. LargeMidCap Value Index;S&P Developed Ex-U.S. LargeMidCap Index;S&P Pan Europe BMI Health Care (Sector) Index;S&P Pan Europe LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P EPAC Ex-Japan BMI Growth Health Care (Sector) Index;S&P EPAC Ex-Japan LargeMidCap Index;S&P EPAC LargeMidCap Value Health Care (Sector) Index;S&P Europe Ex-U.K. LargeMidCap Index;S&P Europe LargeMidCap Growth Health Care (Sector) Index;S&P Europe LargeMidCap Health Care (Sector) Index;S&P Pan Europe BMI Growth Index;S&P Global BMI Growth Index;S&P Switzerland BMI Value Health Care (Sector) Index;S&P Switzerland LargeMidCap Index;S&P Switzerland LargeMidCap Growth Health Care (Sector) Index;S&P Switzerland LargeMidCap Value Health Care (Sector) Index;S&P Switzerland LargeMidCap Growth Index;S&P Switzerland Over USD5 Billion Index;S&P Global Ex-Japan BMI Growth Index;S&P Global Ex-Japan LargeMidCap Growth Index;S&P Global Ex-Pan Asia BMI Index;S&P Global Ex-Pan Asia BMI Growth Index;S&P Global Ex-Pan Asia LargeMidCap Index;S&P Global Ex-U.S. LargeMidCap Index;S&P Global Ex-U.S. LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Global Ex-U.S. Over USD5 Billion Index;S&P Global LargeMidCap Index;S&P Global LargeMidCap Value Index;S&P Pan Europe Over USD5 Billion Index;S&P Switzerland BMI Health Care (Sector) Index;S&P Switzerland BMI Value Index;S&P Switzerland LargeMidCap Value Index;S&P Switzerland BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed BMI Value Health Care (Sector) Index;S&P Developed Ex-Asia-Pacific BMI Health Care (Sector) Index;S&P Developed Ex-Australia LargeMidCap Growth Index;S&P Developed Ex-Canada BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Canada LargeMidCap Growth Index;S&P Developed Ex-Canada LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Canada LargeMidCap Value Index;S&P Developed Ex-Eurozone LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Japan BMI Growth Index;S&P Developed Ex-Japan BMI Value Index;S&P Developed Ex-Japan LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-U.K. LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-U.S. & Japan LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-U.S. & U.K. BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-U.S. & U.K. BMI Value Index;S&P Developed Ex-U.S. & U.K. BMI Value Health Care (Sector) Index;S&P Developed Ex-U.S. LargeMidCap Value Index;S&P Developed Ex-U.S. Over USD5 Billion Index;S&P Developed LargeMidCap Growth Health Care (Sector) Index;S&P Developed LargeMidCap Health Care (Sector) Index;S&P Developed LargeMidCap Value Index;S&P Developed LargeMidCap Value Health Care (Sector) Index;S&P EPAC Ex-Japan LargeMidCap Growth Index;S&P EPAC Ex-Japan LargeMidCap Value Health Care (Sector) Index;S&P EPAC LargeMidCap Health Care (Sector) Index;S&P EPAC LargeMidCap Value Index;S&P Europe BMI Health Care (Sector) Index;S&P Europe Ex-U.K. BMI Value Health Care (Sector) Index;S&P Europe, Mid-East & Africa LargeMidCap Index;S&P Global BMI Health Care (Sector) Index;S&P Global BMI Value Index;S&P Global Ex-Japan BMI Index;S&P Global Ex-U.S. LargeMidCap Health Care (Sector) Index;S&P Global LargeMidCap Growth Index;S&P Pan Europe BMI Index;S&P Pan Europe BMI Value Index;S&P Pan Europe LargeMidCap Growth Index;S&P Pan Europe LargeMidCap Value Index;S&P Switzerland BMI Growth Index;S&P Switzerland BMI Growth Health Care (Sector) Index;S&P Switzerland LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Europe BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P EPAC Ex-Japan BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Eurozone BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-U.S. & Japan BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Canada BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Japan BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Switzerland BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P EPAC BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Europe Ex-UK BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-U.S. & UK BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Asia Pacific BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-U.S. BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Australia BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Eurozone BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P Europe Ex-UK BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P EPAC Ex-Japan BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P Europe BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Canada BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-U.S. & UK BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-U.S. BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P Switzerland BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Asia Pacific BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-U.S. & Japan BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P EPAC BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P Developed BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Japan BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-UK BMI Growth Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-Australia BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P Developed Ex-UK BMI Value Health Care Equipment & Services (Industry Group)  Index;S&P EPAC Ex-Israel BMI Growth Index;S&P EPAC Ex-Israel BMI Growth Health Care (Sector) Index;S&P Developed Ex-Israel BMI Growth Index;S&P Developed Ex-Israel BMI Growth Health Care (Sector) Index;S&P EPAC Ex-Israel BMI Index;S&P EPAC Ex-Israel BMI Health Care (Sector) Index;S&P EPAC Ex-Israel BMI Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Israel BMI Index;S&P Developed Ex-Israel BMI Health Care (Sector) Index;S&P Developed Ex-Israel BMI Health Care Equipment & Services (Industry Group) Index;S&P EPAC Ex-Israel BMI Value Index;S&P EPAC Ex-Israel BMI Value Health Care (Sector) Index;S&P Developed Ex-Israel BMI Value Index;S&P Developed Ex-Israel BMI Value Health Care (Sector) Index;S&P EPAC Ex-Israel LargeMidCap Growth Index;S&P EPAC Ex-Israel LargeMidCap Growth Health Care (Sector) Index;S&P Developed Ex-Israel LargeMidCap Growth Index;S&P Developed Ex-Israel LargeMidCap Growth Health Care (Sector) Index;S&P EPAC Ex-Israel LargeMidCap Index;S&P EPAC Ex-Israel LargeMidCap Health Care (Sector) Index;S&P EPAC Ex-Israel LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P Developed Ex-Israel LargeMidCap Index;S&P Developed Ex-Israel LargeMidCap Health Care (Sector) Index;S&P Developed Ex-Israel LargeMidCap Health Care Equipment & Services (Industry Group) Index;S&P EPAC Ex-Israel LargeMidCap Value Index;S&P EPAC Ex-Israel LargeMidCap Value Health Care (Sector) Index;S&P Developed Ex-Israel LargeMidCap Value Index;S&P Developed Ex-Israel LargeMidCap Value Health Care (Sector) Index;S&P EPAC Ex-Israel Over USD5 Billion Index;S&P Developed Ex-Israel Over USD5 Billion Index;S&P EUROPE 350;S&P EUROPE 350 - Health Care (Sector);S&P EUROPE 350 - Health Care Equipment & Services (Industry Group);S&P Global 1200 - Health Care Equipment & Services (Industry Group);S&P Global 1200 Health Care Equipment & Supplies (Industry);S&P Global 1200 Health Care Supplies (Sub Industry);S&P International 700;S&P International 700 Health Care (Sector);S&P Global Ex-Australia BMI Index;S&P Global Ex-United Kingdom BMI Index;S&P Developed Ex-Japan, Ex-South Korea BMI Index;S&P Developed BMI Ex-U.S. & Korea LargeMidcap Index;S&P Developed BMI Ex-U.S. & Korea Index;S&P EPAC Ex-Korea BMI;S&P EPAC Ex-Korea LargeMidCap;S&P Developed Ex. Japan LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex. Japan LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Global Ex-Australia LargeMidCap;S&P Developed Ex-Japan & South Korea LargeMidCap;S&P Developed Ex-Israel BMI Value Health Care Equipment & Services (Industry Group);S&P EPAC Ex-Israel LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P EPAC Ex-Japan LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-Asia-Pacific LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.K. LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Canada LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Canada LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. & U.K. LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. & U.K. LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P EPAC LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P EPAC LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-Eurozone LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-Israel LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Israel LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P EPAC Ex-Japan LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. & Japan LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P EPAC Ex-Israel BMI Value Health Care Equipment & Services (Industry Group);S&P EPAC Ex-Israel LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-Asia-Pacific LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Australia LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Australia LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.K. LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. & Japan LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Europe LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Israel BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Eurozone LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Europe Ex-U.K. LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P EPAC Ex-Israel BMI Growth Health Care Equipment & Services (Industry Group);S&P Europe Ex-U.K. LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Europe LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Switzerland LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Switzerland LargeMidCap Value Health Care Equipment & Services (Industry Group) (Industry Group);S&P Switzerland LargeMidCap Health Care Equipment & Services (Industry Group) (Industry Group);S&P Global Ex-Australia & New Zealand LargeMidCap;S&P Global Ex-China A BMI;S&P Global Ex-China A LargeMidCap;S&P Global Ex-U.S. & China A BMI;S&P Global Ex-U.S. & China A LargeMidCap;S&P Developed Ex-Korea BMI;S&P Global Ex-Japan & China A LargeMidCap;S&P Developed Ex-Korea LargeMidCap;S&P Developed BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Asia Pacific BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Japan BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Asia Pacific BMI Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-Asia Pacific LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Developed BMI Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-Australia BMI Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. & UK BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. BMI Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-Australia BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Canada BMI Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-UK BMI Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-Eurozone BMI Growth Health Care Equipment & Services (Industry Group);S&P EPAC Ex-Japan BMI Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-Japan LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. & Japan BMI Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. & UK LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P EPAC Ex-Japan BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. & Japan BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-UK LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P EPAC BMI Value Health Care Equipment & Services (Industry Group);S&P Switzerland BMI Value Health Care Equipment & Services (Industry Group);S&P Europe Ex-UK LargeMidCap Value Health Care Equipment & Services (Industry Group);S&P Europe Ex-UK BMI Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-Japan LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Asia Pacific LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Canada BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Eurozone BMI Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-Japan BMI Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. & UK BMI Value Health Care Equipment & Services (Industry Group);S&P Developed Ex-U.S. & UK LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-UK LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-UK BMI Growth Health Care Equipment & Services (Industry Group);S&P EPAC BMI Growth Health Care Equipment & Services (Industry Group);S&P Europe BMI Growth Health Care Equipment & Services (Industry Group);S&P Europe BMI Value Health Care Equipment & Services (Industry Group);S&P Europe Ex-UK BMI Growth Health Care Equipment & Services (Industry Group);S&P Europe Ex-UK LargeMidCap Growth Health Care Equipment & Services (Industry Group);S&P Switzerland BMI Growth Health Care Equipment & Services (Industry Group);S&P Developed Ex-Korea BMI Growth;S&P Developed Ex-Korea BMI Value;S&P Developed Ex-Korea LargeMidCap Growth;S&P Developed Ex-Korea LargeMidCap Value;S&P EPAC Ex-Korea BMI Growth;S&P EPAC Ex-Korea BMI Value;S&P EPAC Ex-Korea LargeMidCap Growth;S&P EPAC Ex-Korea LargeMidCap Value;S&P Global 1200 Ex-Canada;S&P Developed Ex-Korea LargeMidCap Health Care (Sector) Index;Euronext Switzerland 20 PAB;S&P Developed Ex-Korea LargeMidCap Health Care Equipment & Services (Industry Group)


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Current and Pending Subsidiaries / Investments
Company Name
Business Description
Geography
Primary Industry
LTM Total Rev.($mm)
LFQ Total Assets ($mm)
LFQ Total Debt ($mm)
Ivantis, Inc.
Ivantis, Inc. develops solutions for the treatment of primary open angle glaucoma. The company offers Hydrus® Microstent, an intracanalicular scaffold or implantable device that relieves high intraocular pressures in patients. The company offers its solutions for use in clinical trials to ophthalmology specialists in the United States. The company was incorporated in 2007 and is based in Irvine, California. Ivantis, Inc. operates as a subsidiary of Alcon Inc.

United States and Canada
Health Care Equipment
14.00
-
-
TrueVision Systems, Inc.
TrueVision Systems, Inc. develops three-dimensional (3D) stereoscopic visualization systems that display the surgical field of view in real-time on a 3D flat-panel display in operating rooms for microsurgery/neurosurgery. The company offers surgical systems for the astigmatic correction and refractive cataract surgery; software-based guidance systems for pre-operative planning and intra-operative positioning of premium intraocular lenses; computer-aided guidance software applications; a digital microscope platform; a 3D/2D visualization, recording, and editing system; and 3D video streaming and publishing products. It serves surgeons and patients. The company was founded in 2003 and is based in Santa Barbara, California. As of December 19, 2018, TrueVision Systems, Inc. operates as a subsidiary of Alcon, Inc.

United States and Canada
Health Care Equipment
14.00
-
-
Tear Film Innovations Inc.
Tear Film Innovations Inc. develops products for the treatment of evaporative dry eye and related syndromes, including meibomian gland dysfunction (MGD) and blepharitis. Its products includes iLux system, which enables an eye care professional to quickly identify blocked meibomian glands and then apply a painless treatment to unblock the glands and BlephaRx, is used for treating the symptoms and root causes of evaporative dry eye. The company was founded in 2014 and is based in San Diego, California. Tear Film Innovations Inc. operates as a subsidiary of Alcon, Inc. As of December 17, 2018, Tear Film Innovations Inc. operates as a subsidiary of Alcon, Inc.

United States and Canada
Health Care Equipment
-
-
-
ClarVista Medical, Inc.
ClarVista Medical, Inc. develops products to treat ophthalmic conditions in California. It offers HARMONI, a modular intra-ocular lens system that enables to optimize vision in the setting of cataract surgery. ClarVista Medical, Inc. was formerly known as Prospex Medical IV, Inc. The company was incorporated in 2012 and is based in Aliso Viejo, California.

United States and Canada
Health Care Equipment
-
-
-
WaveTec Vision Systems, Inc.
WaveTec Vision Systems, Inc., an ophthalmic medical device company, develops and provides wavefront measurement technology for cataract surgeons. The company offers ORA System, a solution that provides intraoperative refractive information to ophthalmologists worldwide. WaveTec Vision Systems, Inc. was formerly known as AMT Technologies Corp. The company was incorporated in 1997 and is based in Aliso Viejo, California. As of October 16, 2014, WaveTec Vision Systems, Inc. operates as a subsidiary of Alcon, Inc.

United States and Canada
Health Care Equipment
2.00
-
-
Endure Medical, Inc.
Endure Medical, Inc. was acquired by Alcon, Inc. Endure Medical, Inc. designs, develops, and manufactures surgical microscopes, parts, and accessories. The company offers products for ophthalmic, neuro, and spine surgeries; and hand-plastics, and research and laboratory products. It also provides video systems, such as single-chip, 3-chip, HD, and digital recording systems; and video accessories, including flat panel monitors, video towers and carts, digital camera mounts, replacement cables, used camera systems, recording devices, wall and ceiling mounts, beam splitters for microscopes, and adapters with various focal distances. The company was founded in 1987 and is based in Cumming, Georgia.

United States and Canada
Health Care Supplies
-
-
-
LensX Lasers, Inc.
LensX Lasers, Inc. designs and manufactures image-guided femtosecond lasers for refractive cataract surgeries. The company offers INFINITI vision systems; AcrySof IQ Toric IOLs; AcrySof IQ ReSTOR IOL, a multifocal lens that are designed to replace cataractous crystalline lenses and correct presbyopia for a full range of vision; AcrySof IQ ReSTOR Toric IOL for astigmatic patients; AcrySert C Preloaded IOL injector system for implanting the AcrySof IQ IOL; DisCoVisc OVD, a single OVD that is designed for the entire cataract procedure; and DuoVisc Viscoelastic system. Its lasers are used in patients undergoing cataract surgery, including anterior capsulotomy, phacofragmentation, and the creation of single plane and multi-plane arc cuts/incisions in the cornea. The company was incorporated in 2006 and is based in Aliso Viejo, California. As of August 18, 2010, LensX Lasers, Inc. operates as a subsidiary of Alcon, Inc.

United States and Canada
Health Care Equipment
-
-
-


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Nov-08-2021
Jan-10-2022
Merger/Acquisition
Buyer
Ivantis, Inc.
Alcon Inc. (SWX:ALC)
RA Capital Management, L.P.,Mérieux Equity Partners SAS Seller Funds:Mérieux Participations 2, SAS
475.00
Apr-10-2019
-
Shelf Registration
Target
Alcon Inc. (SWX:ALC)


1,292.51
Feb-28-2019
Dec-19-2018
Merger/Acquisition
Buyer
TrueVision Systems, Inc.
Alcon Inc. (SWX:ALC)

146.00
Dec-19-2018
Dec-17-2018
Merger/Acquisition
Buyer
Tear Film Innovations Inc.
Alcon Inc. (SWX:ALC)

145.00
Nov-13-2018
Dec-15-2017
Merger/Acquisition
Buyer
ClarVista Medical, Inc.
Alcon Inc. (SWX:ALC)
New Enterprise Associates, Inc.
125.00
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Oct-05-2023
Company Conference Presentations
Alcon Inc. Presents at European Society of Retina Specialists 2023 Annual Meeting, Oct-05-2023
Sep-26-2023
Company Conference Presentations
Alcon Inc. Presents at Generis American Medical Device (AMD) Summit, Sep-26-2023
Sep-09-2023
Product-Related Announcements
Alcon Reveals Final Data from Its Vivity Registry Study
Aug-16-2023
Earnings Calls
Alcon Inc., Q2 2023 Earnings Call, Aug 16, 2023
Aug-15-2023
Corporate Guidance - Raised
Alcon Inc. Raises Earnings Guidance for the Full Year 2023

Competitors
A.R.C. Laser GmbH, AbbVie Inc. (NYSE:ABBV), Aerie Pharmaceuticals, Inc. (Acquired), Allergan plc, Allergan, Inc., Amneal Pharmaceuticals, Inc. (NYSE:AMRX), Apotex Corp., Apotex Inc., Arbor Pharmaceuticals, LLC, Astellas Pharma Inc. (TSE:4503), Bausch & Lomb Holdings Incorporated, Bausch & Lomb Incorporated, Bausch + Lomb Corporation (NYSE:BLCO), Bausch Health Companies Inc. (NYSE:BHC), Bayer Aktiengesellschaft (XTRA:BAYN), Becton, Dickinson and Company (NYSE:BDX), Boston Scientific Corporation (NYSE:BSX), BVI Medical Inc., Canon Inc. (TSE:7751), Carl Zeiss Meditec AG (XTRA:AFX), Cerner Corporation, CIBA Vision Taiwan Co., Ltd., Combe Incorporated, CooperVision, Inc., Danaher Corporation (NYSE:DHR), Edgewell Personal Care Company (NYSE:EPC), Elekta AB (publ) (OM:EKTA B), EssilorLuxottica Société anonyme (ENXTPA:EL), Fresenius Medical Care AG & Co. KGaA (XTRA:FME), Gaush Meditech Ltd (SEHK:2407), Genentech, Inc., General Electric Company (NYSE:GE), Getinge AB (publ) (OM:GETI B), Ginko International Co., Ltd., Glaukos Corporation (NYSE:GKOS), GSK plc (LSE:GSK), Haleon plc (LSE:HLN), Hikma Pharmaceuticals PLC (LSE:HIK), Hologic, Inc. (NasdaqGS:HOLX), HOYA Corporation (TSE:7741), Hoya Surgical Optics, Inc., ICARES Medicus, Inc. (TPEX:6612), IRIDEX Corporation (NasdaqGM:IRIX), Ivantis, Inc., Johnson & Johnson (NYSE:JNJ), Johnson & Johnson Vision Care, Inc., Koninklijke Philips N.V. (ENXTAM:PHIA), Laserex Technologies Pty. Ltd., LENSAR, Inc. (NasdaqCM:LNSR), Lumenis Be Ltd., Lumibird SA (ENXTPA:LBIRD), Medtronic plc (NYSE:MDT), Menicon Co., Ltd. (TSE:7780), Mondelez International, Inc. (NasdaqGS:MDLZ), New World Medical, Inc., NIDEK CO., LTD., NIDEK Inc., Norlase ApS, Nova Eye Medical Limited (ASX:EYE), Novartis International AG, OD-OS GmbH, Perrigo Company plc (NYSE:PRGO), Prestige Consumer Healthcare Inc. (NYSE:PBH), Quantel (Acquired), Quantel Medical SAS, Rayner Surgical Group Limited, Reckitt Benckiser Group plc (LSE:RKT), Regeneron Pharmaceuticals, Inc. (NasdaqGS:REGN), Roche Holding AG (SWX:ROG), RxSight, Inc. (NasdaqGM:RXST), Sandoz International GmbH, Sanofi (ENXTPA:SAN), Santen Inc., Scholl's Wellness Co., Siemens Healthineers, Inc., Sight Sciences, Inc. (NasdaqGS:SGHT), Smith & Nephew plc (LSE:SN.), St.Shine Optical Co.,Ltd. (TPEX:1565), STAAR Surgical Company (NasdaqGM:STAA), Stryker Corporation (NYSE:SYK), Sunstar Americas, Inc., Sunstar Suisse S.A., Synergetics USA, Inc., Synergy Health Limited, Taro Pharmaceutical Industries Ltd. (NYSE:TARO), Terumo Corporation (TSE:4543), Teva Pharmaceutical Industries Limited (NYSE:TEVA), The Cooper Companies, Inc. (NasdaqGS:COO), The Honey Pot Company, LLC, The Medicines Company, The Procter & Gamble Company (NYSE:PG), Topcon Corporation (TSE:7732), USANA Health Sciences, Inc. (NYSE:USNA), Viatris Inc. (NasdaqGS:VTRS), Visioneering Technologies, Inc. (ASX:VTI), ZEISS Group

M&A Advisors
Blake, Cassels & Graydon LLP, Cravath, Swaine & Moore LLP, Deutsche Bank Aktiengesellschaft (XTRA:DBK), Ernst & Young AG, Freshfields Bruckhaus Deringer LLP, Goldman Sachs & Co. LLC, Greenhill & Co., Inc. (NYSE:GHL), Greenhill & Co., LLC, Hogan Lovells US LLP, Homburger AG, Kaye Scholer LLP, Lazard Freres & Co. LLC, Lazard Ltd (NYSE:LAZ), Locke Lord LLP, McDermott Will & Emery LLP, Pestalozzi Lachenal Patry, Sullivan & Cromwell LLP


Advisors
Most Recent Auditor
PricewaterhouseCoopers LLP
M&A Advisors
Blake, Cassels & Graydon LLP, Cravath, Swaine & Moore LLP, Deutsche Bank Aktiengesellschaft (XTRA:DBK), Ernst & Young AG, Freshfields Bruckhaus Deringer LLP, Goldman Sachs & Co. LLC, Greenhill & Co., Inc. (NYSE:GHL), Greenhill & Co., LLC, Hogan Lovells US LLP, Homburger AG, Kaye Scholer LLP, Lazard Freres & Co. LLC, Lazard Ltd (NYSE:LAZ), Locke Lord LLP, McDermott Will & Emery LLP, Pestalozzi Lachenal Patry, Sullivan & Cromwell LLP
Public Offering Advisors
Cravath, Swaine & Moore LLP, Homburger AG, KPMG LLP


Most Recent Auditor
PricewaterhouseCoopers LLP


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
GlobalData

06:05 AM
ALC
Alcon Inc (ALC.SWX) - Medical Equipment - Deals and Alliances Profile
Reports
80
GlobalData

Oct 04, 2023 11:27 PM
ALC
Alcon Inc (ALC.SWX) - Financial and Strategic SWOT Analysis Review
Reports
244
ValuEngine, Inc.

Oct 02, 2023 02:45 AM
ALC
ValuEngine Rating and Forecast Report for ALC
Reports
11
The Economy Matters

Oct 01, 2023 10:36 PM
ALC
The Economy Matters
Reports
8
CFRA Equity Research
Nurhayati, Wan
Sep 30, 2023 11:14 AM
ALC
Alcon Inc.
Reports
9
GlobalData

Sep 20, 2023 01:17 AM
ALC
Alcon Inc (ALC.SWX) - Financial and Strategic SWOT Analysis Review
Reports
241
Credit Suisse
Credit Suisse European Equity Research
Sep 18, 2023 10:02 AM
ALC
Swiss Medical Equipment & Services: Termination of coverage
Notes
57
Marktfeld
Paraskevopoulos, Michail
Sep 18, 2023 12:24 AM
ALC
Alcon AG: Peer Group Analytics - Q2 FY2023
Reports
34
Marktfeld
Paraskevopoulos, Michail
Sep 17, 2023 07:02 AM
ALC
Alcon AG (ALC.CH): Investor Targeting - September 2023
Reports
14
GlobalData

Sep 15, 2023 06:20 AM
ALC
Alcon Inc (ALC.SWX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Reports
95


Ownership Summary

            Top Holders 
Holders by Type
Holder

Common Stock Equivalent Held

% of Total Shares Outstanding

Market Value (CAD in mm)

Position Date


The Vanguard Group, Inc.

17,990,650

3.65

1,854.6

Jun-30-2023


Aristotle Capital Management, LLC

14,221,033

2.88

1,466.0

Jun-30-2023


Norges Bank Investment Management

11,669,146

2.37

1,202.9

Dec-31-2022


Credit Suisse Asset Management (Switzerland)

11,528,535

2.34

1,188.4

Jun-30-2023


ClearBridge Investments, LLC

9,767,205

1.98

1,006.9

Jun-30-2023


Harding Loevner LP

9,498,428

1.93

979.2

Jun-30-2023


ZKB Asset Management

8,583,909

1.74

884.9

Jun-30-2023


Vontobel Asset Management, Inc.

7,776,683

1.58

801.7

Jun-30-2023


Wellington Management Group LLP

6,932,159

1.41

714.6

Jun-30-2023


AKO Capital LLP

6,519,134

1.32

672.0

Jun-30-2023



 



Top Buyers
Buyers
Common Stock Equivalent Held
Change
Eleva Capital LLP
1,600,528
1,600,528
Deutsche Asset & Wealth Management
3,980,627
1,519,754
The Vanguard Group, Inc.
17,990,650
1,408,526
Sustainable Growth Advisers, LP
3,305,561
1,099,710
Envestnet Asset Management, Inc.
1,024,766
1,024,766

Top Sellers
Sellers
Common Stock Equivalent Held
Change
T. Rowe Price Group, Inc.
0
(6,368,588)
Capital Research and Management Company
53,905
(1,278,638)
Charles Schwab Investment Management, Inc.
6,535
(1,132,992)
Northern Trust Global Investments
802,512
(1,003,562)
ClearBridge Investments, LLC
9,767,205
(892,636)


S&P Global Ratings Credit Ratings
Debt Type (Rating Type)
Current Rating
Rating Date
Current CreditWatch / Outlook
Current CreditWatch / Outlook Date
Issuer Credit Rating (Local Currency LT)
BBB+
Jun-05-2023
Stable
6/5/2023 8:44:30 AM
Issuer Credit Rating (Foreign Currency LT)
BBB+
Jun-05-2023
Stable
6/5/2023 8:44:30 AM


News Headlines
Date/Time
Headline
Source
Sep-07
Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams
India Pharma News
Sep-06
Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams
Business Wire


Company Coverage
This company is not on any Coverage List.

Products
A-OK Opthalmic Knives, Accurus Cassettes and Probes, Accurus Surgical System, ACRYSERT Delivery System, AcrySof Angle-Supported Phakic Lens (Future), AcrySof Aspheric Toric Intraocular Lens, AcrySof Cachet Phakic Lens (Future), AcrySof IOL, AcrySof IQ Aspheric IOL, AcrySof IQ PanOptix Intraocular Lenses, AcrySof IQ PanOptix Trifocal IOL, AcrySof IQ ReSTOR, AcrySof IQ ReSTOR +2.5D Toric IOL, AcrySof IQ ReSTOR +3.0 Diopter Add Power Intraocular Lens, Acrysof Iq Restor +3.0D Multifocal Toric Intraocular Lens, AcrySof IQ ReSTOR 3.0D Toric IOL, AcrySof IQ ReSTOR Distant Dominant (Future), AcrySof IQ ReSTOR Intraocular Lens, AcrySof IQ ReSTOR Multifocal Toric, AcrySof IQ ReSTOR Toric Diopter (Future), AcrySof IQ Toric Diopter (Future), AcrySof IQ Toric Intraocular Lenses, AcrySof IQ Toric Lens, AcrySof IQ Toric Low Diopter (Future), AcrySof IQ Vivity, AcrySof Low Power ReSTOR Lens (Future), ACRYSOF MultiPiece, ACRYSOF MultiPiece - Posterior Convex IOL and EXPAND IOLs, ACRYSOF MultiPiece IOLs, AcrySof Natural, AcrySof Phakic Intraocular Lens, AcrySof ReSTOR, AcrySof ReSTOR +4.0 Diopter Add Power Intraocular Lens, AcrySof ReSTOR Aspheric Intraocular Lens, AcrySof ReSTOR Toric Intraocular Lens, ACRYSOF RESTOR/ IQ RESTOR IOLs, ACRYSOF Single-Piece IOLs, AcrySof Thin-Profile Intraocular Lens (Future), ACRYSOF Toric IOLs, ACTIVE SENTRY Handpiece (Future), Aganocide Compound (Future), Air Optix Colors Contact Lenses, Air Optix Plus HydraGlyde Contact Lenses, AL-37807 (Future), AL-39,324 (Future), AL-43,546 (Future), AL-46,383A (Future), AL-8309b (Future), Alcon Dry Eye Devices, ALLEGRETTO EX-400 Laser, ALLEGRETTO EX-500 Laser (Future), ALLEGRETTO Laser System, ALLEGRETTO WAVE Eye-Q 400 Hz laser, ALLEGRETTO WAVE Eye-Q Excimer Laser System, ALLEGRO ANALYZER Wavefront System, ALLEGRO Biometry System, ALLEGRO OCULYZER Pentacam Diagnostic Device, ALLEGRO TOPOLYZER Corneal Topography System, Alomide, Anterior Chamber Lenses, AquaLase Liquefaction Device, Argos Biometer, AT-IOLs, AutonoMe Delivery Systems, AutonoMe Pre-loaded IOL Delivery System, AZARGA, Azopt Ophthalmic Suspension, Betoptic S, Bion Tears Lubricant Eye Drops, BSS Plus Surgical Solution, Cataract Refractive Suite, Centurion Vision System, CiloDex Otic Solution (Future), Cilomilast (Future), Ciloxan Ophthalmic Solution and Ointment, Cipro HC Otic, CIPRODEX Otic Suspension, Clareon IOL, Clareon Monofocal Intraocular Lenses, Clareon Vivity IOL, CLEAR CARE, CLERZ Plus Lens Rewetting Drops, Color Contact Lenses, CONSTELLATION Vision System, Contoura Vision, Custom Pak Surgical Procedure Packs, CustomCornea Wavefront System, CyPass Micro-Stent, DAILIES AquaComfort Plus, Dailies Colors Contact Lenses, DAILIES TOTAL1, Daily Disposable Lenses, DisCoVisc Ophthalmic Viscosurgical Device, Distribution of JETREA, Distribution of NGENUITY, DuoTrav APS (Future), DuoTrav Solution, DuoVisc Viscoelastic System, Durezol, Emadine, Enhanced OTCtear Substitute (Future), Enhanced Systane Tear Substitute (Future), Ex-PRESS Glaucoma Filtration Device, EX500 Excimer Laser, EXPRESS Contact Lens Care Solutions, EYELITE Photocoagulator, Eyhance Monofocal IOL, Fidelis Virtual Reality Ophthalmic Surgical Simulator, Fluorescite Ophthalmic Solution, Forceps, Freshlook Cosmetic Lenses, FS-200 Femtosecond Laser, Genteal, Genteal Artificial Tears, Grieshaber Disposable Retinal Surgery Instruments, Grieshaber Surgical Instruments, Hand-held Microsurgical Instruments, HETE Prescription Dry Eye Product, Hyaluronic Acid (Future), Hydrogen Peroxide Lens Care Solutions, Hydrus Microstent Device, Hypervit High Speed Vitrectomy Probes, ICAPS, ICAPS AREDS2 (Future), ICAPS Dietary Supplements, ICAPS Enhancement (Future), ICAPS Eye Vitamins, Incisional Instruments, Infiniti Consumables, Infiniti Surgical Instruments, Infiniti Vision System, INTREPID Hybrid Tip (Future), LADAR6000 Excimer Laser, LADARVision 4000 Laser, LADARVision Excimer Laser/system, LADARWave, Laureate Compact Phacoemulsification System, LEGACY Consumables, LEGACY Surgical System, LenSx Femtosecond Laser, LenSx Laser System, LuxOR Ophthalmic Microscope, LuxOR Surgical Ophthalmic Microscopes, Maxitrol, Medical Grade Vitreous Tamponades, MIVS Disposable Retinal Surgery Instruments, Monofocal IOLs, Moxeza 0.5%, Moxifloxacin/dexamethasone (Future), Naphcon A, Naphcon-A, NDA 022193, Nepafenac (Future), NEVANAC Ophthalmic Suspension, NGENUITY3D Visualization System, Ocular Vitamins and Redness Relievers, Olopatadine Hydrochloride Ophthalmic Solution 0.1%, Olopatadine Hydrochloride Ophthalmic Solution 0.2%, Opatanol, OPTI-FREE Contact Lens Care Solutions, OPTI-FREE EVERMOIST Multi-purpose Disinfecting Solution, OPTI-FREE Express MPDS Lasting Comfort Formula, OPTI-FREE EXPRESS No-Rub Contact Lens Care Solution, Opti-Free Multi Purpose Disinfecting Solutions, Opti-Free PureMoist, OPTI-FREE RepleniSH Multi-purpose Disinfecting Solution, OPTI-FREE RepleniSH Rewetting Drops, OPTI-FREE Silicone Hydrogel (Future), OPTI-FREE SupraClens Liquid Enzyme, Opti-One No Rub Multi-Purpose Solution, ORA System, OZil Surgical Instruments, Ozil Torsional Hand Piece, Pataday Once Daily Extra Strength, Pataday Twice Daily Relief, Patanase, Patanol Ophthalmic Solution, Pazeo, Perfluoron Liquid, Precision1, Pred Acetate, ProVisc Ophthalmic Viscosurgical Device, PUREPOINT Laser, Purepoint Laser System and Probes, RETAANE Anecortave Acetate Suspension (Future), Rimexolone Dry Eye Product (Future), Scissors, Silicone Hydrogel Contact Lenses, Silikon Ophthalmic Surgical Oil, Simbrinza, Single Piece PMMA IOLs, SMART Suite Digital Health Platform, SOFZIA Preservative System, STERI-UNITS Ophthalmic Solution, Surgical Packs, Systane Artificial Tears, Systane BALANCE Lubricant Eye Drops, Systane Balance Ocular Emulsion, Systane Complete, SYSTANE Dry Eye Product, Systane Hydration MDPF, Systane iLux MGD Thermal Pulsation System, Systane iLux Thermal Pulsation Dry Eye Device, Systane Lubricant Eye Drops, SYSTANE ULTRA Lubricant Eye Drops, Systane Ultra MDPF, Tears Naturale, Tears Naturale Forte Lubricant Eye Drops, Tears Naturale Lubricant Eye Drops, TobraDex Ophthalmic Suspension, TobraDex ST, Tobramycin, Tobrex Ophthalmic Solution, TOTAL30, TRAVATAN APS (Future), TRAVATAN Ophthalmic Solution, TRAVATAN Z Ophthalmic Solution, TRIESENCE Injectable Suspension (Future), UltraSert IOL Delivery Systems, UltraSert Pre-loaded IOL Delivery System, UltraSert Pre-loaded IOL Delvery System, UltraVit Vitrectomy Probes, UNIQUE-pH Multi-Purpose Solution, Vegamox Ophthalmic Solution, VEGF Protein (Future), Verion Image Guided System, Verion Reference Unit and Verion Digital Marker, Vigadexa Ophthalmic Solution, Vigamox Ophthalmic Solution, VISCOAT, Viscoelastics, Vitalux, Wavefront-Guided Hyperopia, WaveLight EX500 Excimer Laser, WaveLight FS200 Femtosecond Laser, WaveLight Refractive Suite, WaveLight Topolyzer VARIO, WaveNet Planning Station, Zaditor, Zaditor Eye Drops, ZIRGAN Topical Ophthalmic Gel, Zyclorin Ophthalmic Formulation


Upcoming Events
Date/Time
Type
Oct-10-2023
Conferences
Oct-12-2023 10:30 AM (PST)
Company Conference Presentations
Nov-15-2023 8:00 AM (EST)
Earnings Calls
* Future Events are subject to change.


Recent Major Filings

Key Filings
Filed On
Period Date
Company Name
Source
Form Type
Size
Aug-16-2023
Jun-30-2023
Alcon Inc. (SWX:ALC)
Company Website
Preliminary Interim Report
1 MB
Aug-15-2023
Jun-30-2023
Alcon Inc. (SWX:ALC)
SEC
6-K
6 MB
Aug-15-2023
Jun-30-2023
Alcon Inc. (SWX:ALC)
Company Website
Preliminary Interim Report
149 KB
Aug-15-2023
Jun-30-2023
Alcon Inc. (SWX:ALC)
Company Website
Interim Report
304 KB
May-09-2023
Mar-31-2023
Alcon Inc. (SWX:ALC)
SEC
6-K
1 MB
May-09-2023
Mar-31-2023
Alcon Inc. (SWX:ALC)
Company Website
Preliminary Interim Report
1 MB
Mar-30-2023
Mar-29-2023
Alcon Inc. (SWX:ALC)
SEC
6-K
5 MB
Feb-27-2023
Dec-31-2022
Alcon Inc. (SWX:ALC)
SEC
6-K
59 MB
Feb-27-2023
Dec-31-2022
Alcon Inc. (SWX:ALC)
SEC
20-F
230 MB
Feb-27-2023
Dec-31-2022
Alcon Inc. (SWX:ALC)
SEC
6-K
1 MB


Insider Trades
Holder Name
Trade Date Range
Security Type
Transacted Shares
Transaction Value Range (CAD)
Transaction Type
% Change
Source
Narayanan, Rajkumar  (President of International)
Aug-21-2023 3
Common Shares
(3,000)
(342,629)
Intent to Sell (Form 144)
New
Form 144
Attias, Laurent  (Head of Corporate Development, Strategy, BD&L and M&A)
May-16-2023 3
Common Shares
(300)
(33,126)
Intent to Sell (Form 144)
New
Form 144
Fraustro, Leon Sergio Duplan (President of North America)
May-11-2023 3
Common Shares
(11,575)
(1,258,648)
Intent to Sell (Form 144)
New
Form 144
Attias, Laurent  (Head of Corporate Development, Strategy, BD&L and M&A)
May-11-2023 3
Common Shares
(9,524)
(1,040,837)
Intent to Sell (Form 144)
New
Form 144
Stonesifer, Timothy C. (Chief Financial Officer)
Sep-15-2021 3
Common Shares
(6,432)
(763,221)
Intent to Sell (Form 144)
New
Form 144
Excluding Automatic Transactions
Key Board Members Details
Name
Title
Phone
Fax
Email
Ball, F. Michael
Executive Chairman
1 817 293 0450
1 817 916 2652

Endicott, David J.
CEO & Director
1 817 293 0450
1 817 916 2652

Cummings, Arthur B.
Executive Director
1 817 293 0450
1 817 916 2652

Grossman, D. Keith
Independent Director
1 817 293 0450
1 817 916 2652

Maw, Scott Harlan
Independent Director
1 817 293 0450
1 817 916 2652

May, Karen J.
Independent Director
1 817 293 0450
1 817 916 2652

Bleil, Lynn Dorsey
Independent Director
1 817 293 0450
1 817 916 2652

Bono, RaQuel Cruz
Independent Director
1 817 293 0450
1 817 916 2652

Glanzmann, Thomas H.
Independent Director
1 817 293 0450
1 817 916 2652

Poschel, Ines 
Independent Director
1 817 293 0450
1 817 916 2652

Spälti, Dieter
Independent Director
1 817 293 0450
1 817 916 2652
Dieter.spaelti@s-vm.com
* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Ball, F. Michael
Executive Chairman
1 817 293 0450
1 817 916 2652

Endicott, David J.
CEO & Director
1 817 293 0450
1 817 916 2652

Stonesifer, Timothy C.
Chief Financial Officer
1 817 293 0450
1 817 916 2652

Buckley, Margaret 
Chief Accounting Officer
1 817 293 0450
1 817 916 2652
-
Leveiller, Franck 
Senior VP, Head of Global R&D and Chief Scientific Officer
1 817 293 0450
1 817 916 2652

Lin, Sue-Jean 
Senior VP & Chief Information and Transformation Officer
1 817 293 0450
1 817 916 2652

Bedward, Royce R.
Senior VP, General Counsel & Corporate Secretary
1 817 293 0450
1 817 916 2652

Attias, Laurent 
Head of Corporate Development, Strategy, BD&L and M&A
1 817 293 0450
1 817 916 2652

Martin, Kimberly 
Senior VP & Chief HR Officer
1 817 293 0450
1 817 916 2652

Attra, Heather 
Senior VP & Global Head Quality and Regulatory Affairs
1 817 293 0450
1 817 916 2652

Bankes, Jeannette 
President & GM of Global Surgical Franchise
1 817 293 0450
1 817 916 2652

Bell, Ian 
President of Global Business & Innovation
1 817 293 0450
1 817 916 2652

* denotes that the relationship is proprietary

Historical Equity Pricing Data supplied by Interactive Data Pricing and Reference Data LLC 
S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 

**Intraday Quotes are delayed by at least 20 minutes.
